IR
PRAH

Invictus RG’s PRA Health Sciences, Inc. PRAH Stock Holding History

Invictus RG’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,175
Closed -$394K – 556
2017
Q3 		$394K Buy
+5,175
New +$391K 0.36% 102
2016
Q4 		– Sell
-324
Closed -$18K – 814
2016
Q3 		$18K Sell
324
-123
-28% -$6.03K 0.01% 573
2016
Q2 		$19K Sell
447
-2,843
-86% -$131K 0.02% 446
2016
Q1 		$141K Sell
3,290
-5,188
-61% -$219K 0.17% 234
2015
Q4 		$384K Buy
+8,478
New +$356K 0.37% 78

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invictus RG's PRAH Position: Q4 2017 in Review

Invictus RG sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2017, closing a stake of 5,175 shares — an estimated $394K sold.

Invictus RG first reported a position in PRAH in Q4 2015 and held it in 5 quarters. The position peaked at $394K in Q3 2017. 282 funds tracked by Wall St. Rank hold PRAH as of Q4 2017.

  • Invictus RG reported no remaining PRA Health Sciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Invictus RG sold 5,175 PRA Health Sciences, Inc. shares in Q4 2017, an estimated $394K.
  • Invictus RG first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 5 quarters.
  • Invictus RG's PRA Health Sciences, Inc. position peaked at $394K in Q3 2017.
  • 282 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2017.

Based on Invictus RG's 13F filing for Q4 2017, filed 13 Feb 2018.